Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Lapo Alinari
PLK1: A Promising and Previously Unexplored Target in Double-Hit Lymphoma
Journal of Clinical Investigation
Medicine
Phase 2 Trial of Rituximab and Bortezomib in Patients With Relapsed or Refractory Mantle Cell and Follicular Lymphoma
Cancer
Cancer Research
Oncology
Related publications
Double‐hit Lymphoma: So What?
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Double Hit and Double Expressors in Lymphoma: Definition and Treatment
Cancer
Cancer Research
Oncology
Drug Therapy for Double-Hit Lymphoma
Drugs in Context
Molecular Medicine
Pharmacology
The Double Hit Signature Identifies Double-Hit Diffuse Large B-Cell Lymphoma With Genetic Events Cryptic to FISH
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Transformation of Double-Hit Large B-Cell Lymphoma Into B-Lymphoblastic Lymphoma: A Case Report
Journal of Hematopathology
Forensic Medicine
Pathology
Hematology
Histology
Flaviviruses Hit a Moving Target
Cell
Biochemistry
Genetics
Molecular Biology
Cryptic Myc and Bcl2 Rearrangements Are Among a Range of Genetic Mechanisms Underlying the Double Hit Signature in Non-Double Hit Diffuse Large B-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Overexpression of FoxM1 Offers a Promising Therapeutic Target in Diffuse Large B-Cell Lymphoma
Haematologica
Hematology
“Triple-Triple” Hit Lymphoma
Case Reports in Internal Medicine